1. Neela PK, Atteeri A, Mamillapalli PK, et al. Genetics of dentofacial and orthodontic abnormalities. Glob Med Genet. 2020;7(4):95-100. doi:10.1055/s-0040-1722303
2. Nalabothu P, Marya A, Bhaskar LVKS. Gene editing in craniofacial orthodontics. Br Dent J. 2025;239(2):83. doi:10.1038/s41415-025-9020-9
3. Karthika N, Bhat AR. Applications of gene therapy in dentistry: a review article. J Health Allied SciNU. 2023;13(4):445-452. doi:10.1055/s-0042-1759711
4. Geng G, Xu Y, Hu Z, et al. Viral and non-viral vectors in gene therapy: current state and clinical perspectives. EBioMedicine. 2025;118:105834. doi:10.1016/j.ebiom.2025.105834
5. Qie B, Tuo J, Chen F, Ding H, Lyu L. Gene therapy for genetic diseases: challenges and future directions. MedComm (2020). 2025;6(2):e70091. doi:10.1002/mco2.70091
6. Li T, Yang Y, Qi H, et al. CRISPR/Cas9 therapeutics: progress and prospects. Signal Transduct Target Ther. 2023;8(1):36. doi:10.1038/s41392-023-01309-7
7. Song Z, Tao Y, Liu Y, Li J. Advances in delivery systems for CRISPR/Cas-mediated cancer treatment: a focus on viral vectors and extracellular vesicles. Front Immunol. 2024;15:1444437. doi:10.3389/fimmu.2024.1444437
8. Davidson BL, McCray PB Jr. Current prospects for RNA interference-based therapies. Nat Rev Genet. 2011;12(5):329-340. doi:10.1038/nrg2968
9. Kaigler D, Mooney DJ. Tissue engineering’s impact on dentistry. J Dent Educ. 2001;65(5):456-462.
10. Nakashima M, Akamine A. The application of tissue engineering to regeneration of pulp and dentin in endodontics. J Endod. 2005;31(10):711-718. doi:10.1097/01.don.0000164138.49923.e5
11. Ishii T. Germline genome-editing research and its socioethical implications. Trends Mol Med. 2015;21(8):473-481. doi:10.1016/j.molmed.2015.05.006
12. Lundstrom K. Viral vectors in gene therapy. Diseases. 2018;6(2):42. doi:10.3390/diseases6020042
13. Gupta PK. Genetics: Classical to Modern. New Delhi: Rastogi Publications; 2007.
14. Wirth T, Parker N, Ylä-Herttuala S. History of gene therapy. Gene. 2013;525(2):162-169. doi:10.1016/j.gene.2013.03.137
15. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000;288(5466):669-672. doi:10.1126/science.288.5466.669
16. Ginn SL, Alexander IE, Edelstein ML, Abedi MR, Wixon J. Gene therapy clinical trials worldwide to 2012-an update. J Gene Med. 2013;15(2):65-77. doi:10.1002/jgm.2698
17. Frangoul H, Altshuler D, Cappellini MD, et al. CRISPR-Cas9 gene editing for sickle cell disease and ß-thalassemia. N Engl J Med. 2021;384(3):252-260. doi:10.1056/NEJMoa2031054
18. Rainov NG. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther. 2000;11(17):2389-2401. doi:10.1089/104303400750038499
19. Alton EWFW, Armstrong DK, Ashby D, et al. Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir Med. 2015;3(9):684-691. doi:10.1016/S2213-2600(15)00245-3
20. Baum BJ, Zheng C, Cotrim AP, et al. Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction. Biochim Biophys Acta. 2006;1758(8):1071-1077. doi:10.1016/j.bbamem.2005.11.006
21. Kaigler D, Pagni G, Park CH, et al. Stem cell therapy for craniofacial bone regeneration: a randomized, controlled feasibility trial. Cell Transplant. 2013;22(5):767-777. doi:10.3727/096368912X652968